Literature DB >> 24710615

Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades.

Jeffrey L Jones1, Deanna Kruszon-Moran2, Hilda N Rivera2, Courtney Price2, Patricia P Wilkins2.   

Abstract

Toxoplasma gondii is a ubiquitous parasite that can cause neurologic and ocular disease. We tested sera from 7,072 people ≥ 6 years of age in the 2009-2010 National Health and Nutrition Examination Survey (NHANES) for immunoglobulin G antibodies and compared these results with two previous NHANES studies. The overall T. gondii antibody seroprevalence among persons ≥ 6 years of age in 2009-2010 was 13.2% (95% confidence limit [CL] 11.8%, 14.5%) and age-adjusted seroprevalence was 12.4% (95% CL 11.1%, 13.7%); age-adjusted seroprevalence among women 15-44 years of age was 9.1% (95% CL 7.2%, 11.1%). In U.S. born persons 12-49 years of age, the age-adjusted T. gondii seroprevalence decreased from 14.1% (95% CL 12.7%, 15.5%) in NHANES III (1988-1994) to 9.0% (95% CL 7.6%, 10.5%) in NHANES 1999-2004 to 6.7% (95% CL 5.3%, 8.2%) in NHANES 2009-2010 (P < 0.001 linear trend). Although T. gondii antibody presence is still relatively common, the prevalence in the United States has continued to decline. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710615      PMCID: PMC4047742          DOI: 10.4269/ajtmh.14-0013

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.

Authors:  E Fuller Torrey; John J Bartko; Zhao-Rong Lun; Robert H Yolken
Journal:  Schizophr Bull       Date:  2006-11-03       Impact factor: 9.306

2.  National health and nutrition examination survey: analytic guidelines, 1999-2010.

Authors:  Clifford L Johnson; Ryne Paulose-Ram; Cynthia L Ogden; Margaret D Carroll; Deanna Kruszon-Moran; Sylvia M Dohrmann; Lester R Curtin
Journal:  Vital Health Stat 2       Date:  2013-09

3.  Annual burden of ocular toxoplasmosis in the US.

Authors:  Jeffrey L Jones; Gary N Holland
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

4.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors.

Authors:  J L Jones; D Kruszon-Moran; M Wilson; G McQuillan; T Navin; J B McAuley
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

Review 5.  Preventing congenital toxoplasmosis.

Authors:  A Lopez; V J Dietz; M Wilson; T R Navin; J L Jones
Journal:  MMWR Recomm Rep       Date:  2000-03-31

6.  Identification of a sporozoite-specific antigen from Toxoplasma gondii.

Authors:  Dolores Hill; Cathleen Coss; J P Dubey; Kristen Wroblewski; Mari Sautter; Tiffany Hosten; Claudia Muñoz-Zanzi; Ernest Mui; Shawn Withers; Kenneth Boyer; Gretchen Hermes; Jessica Coyne; Frank Jagdis; Andrew Burnett; Patrick McLeod; Holmes Morton; Donna Robinson; Rima McLeod
Journal:  J Parasitol       Date:  2011-03-03       Impact factor: 1.276

7.  Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.

Authors:  Kenneth Boyer; Dolores Hill; Ernest Mui; Kristen Wroblewski; Theodore Karrison; J P Dubey; Mari Sautter; A Gwendolyn Noble; Shawn Withers; Charles Swisher; Peter Heydemann; Tiffany Hosten; Jane Babiarz; Daniel Lee; Paul Meier; Rima McLeod
Journal:  Clin Infect Dis       Date:  2011-10-21       Impact factor: 9.079

8.  Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders.

Authors:  Timothy A Arling; Robert H Yolken; Manana Lapidus; Patricia Langenberg; Faith B Dickerson; Sarah A Zimmerman; Theodora Balis; Johanna A Cabassa; Debra A Scrandis; Leonardo H Tonelli; Teodor T Postolache
Journal:  J Nerv Ment Dis       Date:  2009-12       Impact factor: 2.254

9.  Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade.

Authors:  Jeffrey L Jones; Deanna Kruszon-Moran; Kolby Sanders-Lewis; Marianna Wilson
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

Review 10.  Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.

Authors:  Georgios Pappas; Nikos Roussos; Matthew E Falagas
Journal:  Int J Parasitol       Date:  2009-05-09       Impact factor: 3.981

View more
  49 in total

1.  Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.

Authors:  Joseph Lykins; Kanix Wang; Kelsey Wheeler; Fatima Clouser; Ashtyn Dixon; Kamal El Bissati; Ying Zhou; Christopher Lyttle; Andrey Rzhetsky; Rima McLeod
Journal:  Clin Infect Dis       Date:  2016-06-26       Impact factor: 9.079

Review 2.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 3.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

4.  Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.

Authors:  Ajay R Bharti; Allen McCutchan; Reena Deutsch; Davey M Smith; Ronald J Ellis; Mariana Cherner; Steven P Woods; Robert K Heaton; Igor Grant; Scott L Letendre
Journal:  Clin Infect Dis       Date:  2016-10-28       Impact factor: 9.079

5.  Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level.

Authors:  Mona Ibrahim Ali; Wegdan Mohamed Abd El Wahab; Doaa Ahmed Hamdy; Ahmed Hassan
Journal:  J Parasit Dis       Date:  2019-03-30

6.  Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States.

Authors:  Reshika Dhakal; Kiran Gajurel; Christelle Pomares; Jeanne Talucod; Cynthia J Press; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

7.  Prevalence of Toxoplasma gondii infection in HIV-infected patients and food animals and direct genotyping of T. gondii isolates, Southern Ghana.

Authors:  Faustina Pappoe; Weisheng Cheng; Lin Wang; Yuanling Li; Dorcas Obiri-Yeboah; Samuel Victor Nuvor; Henock Ambachew; Xiaodong Hu; Qingli Luo; Deyong Chu; Yuanhong Xu; Jilong Shen
Journal:  Parasitol Res       Date:  2017-04-22       Impact factor: 2.289

8.  Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay.

Authors:  Ai Ying Teh; Atefeh Amerizadeh; Sabariah Osman; Muhammad Hafiznur Yunus; Rahmah Noordin
Journal:  Pathog Glob Health       Date:  2016-10-04       Impact factor: 2.894

9.  Early life socioeconomic position and immune response to persistent infections among elderly Latinos.

Authors:  Helen C S Meier; Mary N Haan; Carlos F Mendes de Leon; Amanda M Simanek; Jennifer B Dowd; Allison E Aiello
Journal:  Soc Sci Med       Date:  2016-07-05       Impact factor: 4.634

10.  Toxoplasma gondii Infection in the United States, 2011-2014.

Authors:  Jeffrey L Jones; Deanna Kruszon-Moran; Scott Elder; Hilda N Rivera; Cindy Press; Jose G Montoya; Geraldine M McQuillan
Journal:  Am J Trop Med Hyg       Date:  2017-12-14       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.